Literature DB >> 18438835

The HLA-DRB1 shared epitope in Caucasians with rheumatoid arthritis: a lesson learned from tic-tac-toe.

S Louis Bridges, James M Kelley, Laura B Hughes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18438835      PMCID： PMC3768277          DOI： 10.1002/art.23433

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  18 in total

1.  HLA-DRB1 alleles encoding an aspartic acid at position 70 protect against development of rheumatoid arthritis.

Authors:  D L Mattey; P T Dawes; M A Gonzalez-Gay; C Garcia-Porrua; W Thomson; A H Hajeer; W E Ollier
Journal:  J Rheumatol       Date:  2001-02       Impact factor: 4.666

Review 2.  The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis.

Authors:  P K Gregersen; J Silver; R J Winchester
Journal:  Arthritis Rheum       Date:  1987-11

3.  Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1.

Authors:  J H Brown; T S Jardetzky; J C Gorga; L J Stern; R G Urban; J L Strominger; D C Wiley
Journal:  Nature       Date:  1993-07-01       Impact factor: 49.962

4.  Rheumatoid arthritis may be primarily associated with HLA-DR4 molecules sharing a particular sequence at residues 67-74.

Authors:  K S Rønningen; A Spurkland; T Egeland; T Iwe; E Munthe; F Vartdal; E Thorsby
Journal:  Tissue Antigens       Date:  1990-11

5.  Influence of shared epitope-negative HLA-DRB1 alleles on genetic susceptibility to rheumatoid arthritis.

Authors:  D Reviron; A Perdriger; E Toussirot; D Wendling; N Balandraud; S Guis; G Semana; P Tiberghien; P Mercier; J Roudier
Journal:  Arthritis Rheum       Date:  2001-03

6.  Reshaping the shared epitope hypothesis: HLA-associated risk for rheumatoid arthritis is encoded by amino acid substitutions at positions 67-74 of the HLA-DRB1 molecule.

Authors:  Niek de Vries; Henk Tijssen; Piet L C M van Riel; Leo B A van de Putte
Journal:  Arthritis Rheum       Date:  2002-04

7.  The influence of genetic variation in the HLA-DRB1 and LTA-TNF regions on the response to treatment of early rheumatoid arthritis with methotrexate or etanercept.

Authors:  Lindsey A Criswell; Raymond F Lum; Kevin N Turner; Blanche Woehl; Yuanqing Zhu; Jinyi Wang; Hemant K Tiwari; Jeffrey C Edberg; Robert P Kimberly; Larry W Moreland; Michael F Seldin; S Louis Bridges
Journal:  Arthritis Rheum       Date:  2004-09

8.  Association of the B-cell alloantigen DRw4 with rheumatoid arthritis.

Authors:  P Stastny
Journal:  N Engl J Med       Date:  1978-04-20       Impact factor: 91.245

9.  Protective HLA-DR phenotypes in rheumatoid arthritis.

Authors:  B A Larsen; C A Alderdice; D Hawkins; J R Martin; D M Mitchell; D P Sheridan
Journal:  J Rheumatol       Date:  1989-04       Impact factor: 4.666

10.  The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis.

Authors:  C M Weyand; K C Hicok; D L Conn; J J Goronzy
Journal:  Ann Intern Med       Date:  1992-11-15       Impact factor: 25.391
View more
  4 in total

1.  Hierarchy of risk of childhood-onset rheumatoid arthritis conferred by HLA-DRB1 alleles encoding the shared epitope.

Authors:  Sampath Prahalad; Susan D Thompson; Karen N Conneely; Yunxuan Jiang; Traci Leong; Jennifer Prozonic; Milton R Brown; Lori A Ponder; Sheila T Angeles-Han; Larry B Vogler; Christine Kennedy; Carol A Wallace; Carol A Wise; Marilynn Punaro; Ann Reed; Jane L Park; Elizabeth D Mellins; Andrew S Zeft; John F Bohnsack; David N Glass
Journal:  Arthritis Rheum       Date:  2012-03

2.  The role of HLA-DR-DQ haplotypes in variable antibody responses to anthrax vaccine adsorbed.

Authors:  N M Pajewski; S D Parker; G A Poland; I G Ovsyannikova; W Song; K Zhang; B A McKinney; V S Pankratz; J C Edberg; R P Kimberly; R M Jacobson; J Tang; R A Kaslow
Journal:  Genes Immun       Date:  2011-03-03       Impact factor: 2.676

3.  Influence of HLA DRB1 alleles in the susceptibility of rheumatoid arthritis and the regulation of antibodies against citrullinated proteins and rheumatoid factor.

Authors:  Alejandro Balsa; Arancha Cabezón; Gisela Orozco; Tatiana Cobo; Eugenia Miranda-Carus; Miguel Angel López-Nevot; José Luis Vicario; Emilio Martín-Mola; Javier Martín; Dora Pascual-Salcedo
Journal:  Arthritis Res Ther       Date:  2010-04-06       Impact factor: 5.156

4.  Pharmacogenetics of rheumatoid arthritis: Potential targets from susceptibility genes and present therapies.

Authors:  Darren D O'Rielly; Proton Rahman
Journal:  Pharmgenomics Pers Med       Date:  2010-03-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.